This is the authors' abstract. We don't add key points for this paper.
Trigeminal neuralgia (TN) is a chronic neuropathic pain disorder characterized by recurrent episodes of sudden, electric shock-like pain in the distribution of the trigeminal nerve (cranial nerve V). The condition is associated with significant morbidity and can severely impact quality of life. While antiepileptic medications remain the first-line treatment, botulinum toxin (BoNT) has emerged as a safe and effective alternative, particularly in cases refractory to conventional therapies. This case report describes a patient with idiopathic TN who demonstrated significant symptom relief following treatment with incobotulinum toxin a (incoBoNT/A), highlighting its potential role in the management of TN.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lau et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: